Want to see NL:DSFIR full AI Analyst Report?
DSFIR Stock Chart & Stats
€65.76
-€3.96(-3.87%)
At close: 4:00 PM EST
€65.76
-€3.96(-3.87%)
Day’s Range― - ―
52-Week Range€55.22 - €91.38
Previous CloseN/A
Volume698.62K
Average Volume (3M)727.24K
Market Cap
€19.68B
Enterprise Value€22.04B
Total Cash (Recent Filing)€1.90B
Total Debt (Recent Filing)€5.28B
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Jul 30, 2026EPS Estimate
0.89Next Dividend Ex-DateN/A
Dividend Yield3.61%
Share Statistics
EPS (TTM)-4.16
Shares Outstanding253,626,950
10 Day Avg. Volume620,056
30 Day Avg. Volume727,238
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.98
Price to Sales (P/S)1.97
P/FCF Ratio28.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€76.43Price Target Upside16.22% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)3.52
Revenue Forecast (FY)€9.17B
Bulls Say, Bears Say
Bulls Say
Manageable Leverage And Solid Equity CushionA contained balance-sheet profile with moderate leverage and a sizable equity base gives the company durable financial flexibility. This supports continued R&D, commercial investment, dividend capacity and resilience to sector shocks over the next several months, lowering solvency risk.
Positive Operating And Free Cash FlowConsistent positive operating and free cash flow underpin the company's ability to fund operations, customer support and incremental innovation without relying solely on external financing. Even with a recent decline, persistent cash generation supports durability of operations and strategic optionality.
Diversified B2B Ingredient Portfolio And Embedded Customer RelationshipsA broad portfolio across perfumery, flavors, nutrition and formulation services plus embedded, multi-year B2B customer relationships creates structural revenue stickiness. Value-added co-creation and regulatory support deepen customer integration and support recurring demand and pricing leverage over time.
Bears Say
Sizable Net Loss And Volatile ProfitabilityA swing to a large net loss signals earnings instability and potential one-off or structural cost pressures. Even with operating profitability intact, bottom-line volatility undermines predictability for cash returns, capital allocation and could force margin remediation or cost cuts over the medium term.
Weakened Cash Conversion And Declining Free Cash Flow In 2025Deteriorating free cash flow and erratic cash conversion reduce the company's buffer to absorb shocks or invest organically. Over several months a worsening cash conversion profile constrains reinvestment, deleveraging and shareholder returns unless operational trends stabilize.
Sharp Revenue And EPS DeclinesSteep declines in reported revenue and EPS growth indicate weakening demand or adverse mix changes. If persistent, these trends pressure margins, reduce economies of scale and erode the equity cushion, making capital allocation and long-term strategic initiatives more difficult to sustain.
DSM-Firmenich AG News
DSFIR FAQ
What was DSM-Firmenich AG’s price range in the past 12 months?
DSM-Firmenich AG lowest stock price was €55.22 and its highest was €91.38 in the past 12 months.
What is DSM-Firmenich AG’s market cap?
DSM-Firmenich AG’s market cap is €19.68B.
When is DSM-Firmenich AG’s upcoming earnings report date?
DSM-Firmenich AG’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were DSM-Firmenich AG’s earnings last quarter?
DSM-Firmenich AG released its earnings results on Feb 12, 2026. The company reported €0.647 earnings per share for the quarter, missing the consensus estimate of €1.025 by -€0.378.
Is DSM-Firmenich AG overvalued?
According to Wall Street analysts DSM-Firmenich AG’s price is currently Undervalued.
Does DSM-Firmenich AG pay dividends?
DSM-Firmenich AG pays a Annually dividend of €2.5 which represents an annual dividend yield of 3.61%. See more information on DSM-Firmenich AG dividends here
What is DSM-Firmenich AG’s EPS estimate?
DSM-Firmenich AG’s EPS estimate is 0.89.
How many shares outstanding does DSM-Firmenich AG have?
DSM-Firmenich AG has 253,626,950 shares outstanding.
What happened to DSM-Firmenich AG’s price movement after its last earnings report?
DSM-Firmenich AG reported an EPS of €0.647 in its last earnings report, missing expectations of €1.025. Following the earnings report the stock price went down -8.454%.
Which hedge fund is a major shareholder of DSM-Firmenich AG?
Currently, no hedge funds are holding shares in NL:DSFIR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
DSFIR Stock 12 Month Forecast
Average Price Target
€76.43
▲(16.22% Upside)
Technical Analysis
Akzo Nobel NV
―
AMG ADVANCED METALLURGICAL GROUP NV
―
Aperam S.A.
―
ArcelorMittal
―
OCI N.V.
―
Options Prices
Currently, No data available
---







